Family Medicine Conference Details

Bone Health 2014 CME

Date: March 29, 2014
Location: Dallas, Texas 75390, United States
Email: veronica.mason@utsouthwestern.edu
Description: The aim of this symposium is to provide the latest knowledge and discuss controversies related to the pathogenesis and management of primary osteoporosis and drug-induced osteoporosis as well as covering current topics on mineral disorders in special populations such as patients with chronic kidney disease or kidney stones. The format of this symposium will be a series of lectures presented by experts in the field on a variety of topics followed by panel discussions where the audience can directly interact with the speakers.

7.25 AMA PRA Category 1 Credits™ - maximum

Venue: UT Southwestern Medical Center

Prepare for this Meeting

Read Article Summaries From Top Medical Journals

1 Dietary intake of fiber, fruit, and vegetables decrease the risk of incident kidney stones in women: A Women's Health Initiative (WHI) report The Journal of Urology, June 9, 2014
2 The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine Journal of Bone and Mineral Research, May 6, 2014
3 Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study BMJ, July 11, 2014 Evidence Based Medicine
4 Risk factors for the development of osteoporosis after spinal cord injury. A 12-month follow-up study Osteoporosis International, May 14, 2015
5 Climate change may bring more kidney stones The Children's Hospital of Philadelphia, July 11, 2014

Related Quizzes From Smartest Doc

Question:

Which outcome is significantly greater with daily teriparatide in patients with postmenopausal osteoporosis and RA compared to those with only postmenopausal osteoporosis?

What would you do now?

Take the Quiz

Question:

True or False: In contrast to obese kidney stone formers (KSF), overweight KSF do not show clear alterations in metabolic urinary profiles that are associated with increased overall risk of stone formation compared to normal weight KSF.

What would you do now?

Take the Quiz

Question:

True or false: Prolonged reduction in bone turnover during 10 years of therapy with alendronate leads to adverse effects on bone material properties in postmenopausal women.

What would you do now?

Take the Quiz

Latest Family Med Articles

 

Be Ready for Upcoming 2015 Board Exams!

Be prepared for board reviews with confidence with 1000s of board exam style questions. Prepare Here